Kwan-Ho (Alex)
Chung, Ph.D.He / Him / His

Partner
LANGUAGES
Korean
Profile

Overview

Leveraging more than 15 years of experience in both life sciences and patent law, Alex Chung advises on patent counseling, prosecution, transactions and litigation in the life sciences sector, encompassing biotechnology, pharmaceuticals, chemicals and medical devices. He counsels on strategic global patent portfolio development and management; offensive/defensive IP due diligence; patentability, infringement, landscape, validity and freedom-to-operate (FTO) analyses; and IP licensing.

Clients ranging from startups to global conglomerates benefit from Alex’s in-depth understanding of the life sciences industry, combined with his extensive patent law knowledge spanning the full life cycle from invention to litigation. Alex has patent dispute experience before the federal district courts, the U.S. International Trade Commission (ITC) and the Patent Trial and Appeal Board (PTAB), as well as in European opposition proceedings. His IP litigation experience further includes trade secrets and contract disputes.

Alex’s technical experience includes:

  • Antibody therapeutics (multi-specific/engineered antibodies, ADCs including linkers/payloads/novel formats)
  • Nucleic acid therapeutics (RNAi, CRISPR genome editing, miRNA/siRNA, circRNA, ASO, LNA)
  • Gene therapy (AAV)
  • Cell therapy (CAR/TCR-T, cytokine)
  • Targeted protein degradation (PROTAC, MG)
  • Small molecule pharmaceuticals and chemicals (lithium-ion batteries, radiopharmaceuticals)
  • Peptides (oral, adaptor fusion)
  • Neurodegenerative diseases
  • Immuno-oncology
  • Neuro-immunology
  • Drug repurposing
  • Enzyme replacement therapy
  • Genomics
  • Molecular diagnostics
  • Regenerative medicine (MSCs, dental stem cells)
  • Medical devices
  • Artificial intelligence (AI)

Before attending law school, Alex researched neural development and AAV gene therapy vectors as a postdoctoral fellow at the National Institutes of Health (NIH). He is a co-inventor of a U.S. patent for an RNAi vector, commercially licensed to and marketed by the largest U.S. supplier of scientific reagents and instrumentation.

Credentials
Clerkships

Judicial Intern to the Hon. Jimmie V. Reyna, U.S. Court of Appeals for the Federal Circuit, Washington, D.C.

Education

J.D., George Washington University Law School, 2012

Ph.D., Neuroscience, University of Michigan Medical School, 2007

M.S., Immunology & Genetic Engineering, Seoul National University, 1997

B.S., Microbiology, Seoul National University, 1996

Admissions

District of Columbia

New York

U.S. Patent and Trademark Office

Honors

Ones to Watch, Litigation - Patent Law; Patent Law, Best Lawyers, 2023

Legal 500 Recommended Lawyer 2025